Rose Merc Limited Allots 4,21,111 Convertible Warrants to Non-Promoter Investors

2 min read     Updated on 28 Mar 2026, 03:23 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Rose Merc Limited successfully allotted 4,21,111 convertible warrants to nine non-promoter investors on March 27, 2026, at Rs. 90 per warrant for total consideration of Rs. 3,78,99,990. The company received Rs. 94,74,997.50 as initial payment representing 25% of the total consideration. Each warrant is convertible into one equity share within 18 months, with the largest allocation going to Sachin Deshpande (1,27,778 warrants).

powered bylight_fuzz_icon
36194032

*this image is generated using AI for illustrative purposes only.

Rose merc Limited has completed the allotment of 4,21,111 convertible warrants to non-promoter investors on March 27, 2026. The allotment committee, which convened from 4:30 p.m. to 4:45 p.m., approved the issuance following BSE's in-principal approval granted vide letter no. LOD/PREF/DA/FIP/1859/2025-26 dated March 12, 2026.

Warrant Allotment Details

The convertible warrants were issued at Rs. 90 per warrant, including a premium of Rs. 80. Each warrant is convertible into one equity share at any time within 18 months from the date of allotment. The total consideration for the preferential issue amounts to Rs. 3,78,99,990.

Parameter: Details
Total Warrants Allotted: 4,21,111
Issue Price per Warrant: Rs. 90 (including premium of Rs. 80)
Total Consideration: Rs. 3,78,99,990
Initial Payment Received: Rs. 94,74,997.50 (25% of total)
Conversion Period: 18 months from allotment date
Number of Allottees: 9 investors

Investor Distribution

The warrants were allocated among nine non-promoter investors, with Sachin Deshpande receiving the largest allocation of 1,27,778 warrants, followed by Salil Divakar Deshpande with 83,333 warrants.

Sr. No.: Name of Allottees Category No. of Warrants Allotted
1. Dipali Dattatray Jadhav Non-Promoter 17,250
2. Kavita Deshpande Non-Promoter 50,000
3. Poonam Sachin Gaikwad Non-Promoter 750
4. Punam Arora Non-Promoter 51,000
5. Sachin Deshpande Non-Promoter 1,27,778
6. Salil Divakar Deshpande Non-Promoter 83,333
7. Samindar Shankar Jadhav Non-Promoter 1,000
8. Vikas Pandurang Kolarkar Non-Promoter 50,000
9. Omprakash Singh Non-Promoter 40,000
Total: 4,21,111

Regulatory Compliance and Conversion Terms

The preferential issue was conducted pursuant to Chapter V of the SEBI ICDR Regulations, 2018, and applicable provisions of the Companies Act, 2013. The company has received Rs. 94,74,997.50, equivalent to 25% of the aggregate consideration as required under the regulations.

The proposed allottees must pay the remaining 75% of the consideration before converting warrants into equity shares. Each warrant can be converted into one equity share with a face value of Rs. 10. The warrants are convertible in one or more tranches within the specified 18-month tenure from the allotment date.

Historical Stock Returns for Rose Merc

1 Day5 Days1 Month6 Months1 Year5 Years
-0.19%+0.36%+0.13%+4.44%+55.40%+1,778.23%

How will Rose Merc Limited utilize the Rs. 3.79 crore proceeds from this warrant conversion to drive business growth over the next 18 months?

What impact could the potential 30% dilution in equity have on existing shareholders' voting rights and earnings per share?

Will the concentrated ownership among the Deshpande family members (holding over 62% of warrants) influence the company's strategic direction?

Rose Merc Limited Completes Equity Warrant Allotment and Major Corporate Restructuring

2 min read     Updated on 25 Mar 2026, 02:35 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Rose Merc Limited successfully concluded its March 24, 2026 board meeting with major corporate developments including completion of equity warrant allotment worth ₹3.20 crores to 13 investors, strategic appointment of Vikas Phadnis as advisor, subsidiary restructuring with two companies transitioning to associate status, and acquisition of 48% stake in organic healthcare company Abaca Care Private Limited.

powered bylight_fuzz_icon
35380077

*this image is generated using AI for illustrative purposes only.

Rose Merc Limited has successfully completed its board meeting held on March 24, 2026, announcing significant corporate developments including the allotment of equity warrants, subsidiary status changes, and strategic appointments. The board meeting, which commenced at 4:00 PM and concluded at 5:45 PM, addressed multiple key agenda items in compliance with SEBI regulations.

Equity Warrant Allotment Completed

The company has successfully allotted 3,55,723 equity warrants convertible into equity shares on a preferential basis for cash. This follows the in-principal approval granted by BSE vide letter no. LOD/PREF/DA/FIP/1859/2025-26 dated March 11, 2026.

Parameter: Details
Total Warrants Allotted: 3,55,723
Issue Price per Warrant: ₹90.00 (including premium of ₹80.00)
Total Consideration: ₹3,20,15,070.00
Amount Received (25%): ₹80,03,767.50
Conversion Period: 18 months from allotment date

Warrant Allottee Distribution

The warrants have been allocated among 13 investors across promoter and non-promoter categories. The largest individual allocation went to Tanveersingh Ahuja with 1,11,000 warrants, followed by Amitkumar Yogendra Singh and Niti Trivedi with 55,556 warrants each.

Allottee Name: Category Warrants Allotted
Tanveersingh Ahuja: Non-Promoter 1,11,000
Amitkumar Yogendra Singh: Non-Promoter 55,556
Niti Trivedi: Non-Promoter 55,556
Vikas Kamlakar Phadnis: Non-Promoter 50,000
Vedika Thakur: Non-Promoter 40,000
Vijay Acharya: Non-Promoter 30,000
Kirti Chunilal Savla: Promoter 11,111
Others (6 investors): Non-Promoter 2,250
Total: Both Categories 3,55,723

Subsidiary Status Changes

The board approved significant changes in subsidiary holdings, resulting in two companies transitioning from subsidiary to associate status:

Rahi Pakhle RM Private Limited: Following director resignation from the board, the company's status changed to associate. The entity contributed ₹75,000 in revenue (0.009% of total) and had a net worth of ₹58,330 (0.017% of total).

Kaale and Rose Merc Advisors Private Limited: The board approved the sale of 49% equity stake for ₹49,000, along with director resignation, changing its status to associate company. The entity generated ₹5,70,000 in revenue (0.072% of total) with a negative net worth of ₹1,65,612.06.

Company: Revenue Net Worth Status Change
Rahi Pakhle RM Pvt Ltd: ₹75,000 (0.009%) ₹58,330 (0.017%) Subsidiary to Associate
Kaale and Rose Merc Advisors: ₹5,70,000 (0.072%) -₹1,65,612.06 (-0.049%) Subsidiary to Associate

Strategic Appointments and New Acquisition

The board appointed Mr. Vikas Phadnis as Advisor-Strategy and Growth. Phadnis brings extensive experience as co-founder of Lighthouse Learning Group and has successfully built education enterprises over two decades.

Additionally, the company completed its investment in Abaca Care Private Limited, acquiring a 48% stake for ₹48,000. The target company operates in the organic healthcare sector, developing homeopathy pain relief products, and was incorporated on May 17, 2023.

Investment Details: Specifications
Target Company: Abaca Care Private Limited
Stake Acquired: 48%
Investment Amount: ₹48,000
Industry: Organic healthcare
Status: Now subsidiary of Rose Merc
Incorporation Date: May 17, 2023

The comprehensive board meeting outcome reflects Rose Merc Limited's strategic focus on capital raising through warrant allotment while optimizing its subsidiary portfolio and strengthening advisory capabilities for future growth initiatives.

Historical Stock Returns for Rose Merc

1 Day5 Days1 Month6 Months1 Year5 Years
-0.19%+0.36%+0.13%+4.44%+55.40%+1,778.23%

What strategic initiatives will Rose Merc pursue with the ₹3.2 crore raised through warrant allotment, and how might this impact their market positioning?

How will the conversion of equity warrants over the next 18 months affect Rose Merc's shareholding structure and potential dilution for existing shareholders?

What synergies does Rose Merc expect to achieve through its 48% acquisition of Abaca Care in the organic healthcare sector?

More News on Rose Merc

1 Year Returns:+55.40%